Home / SRNE : OTC

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does SRNE make money? Does SRNE have pricing power? What's the Earnings Whisper? Will SRNE profit more as the business scales? What is SRNE's management track record? Is SRNE's current price justified?

Sorrento Therapeutics, Inc.

$0 -$0.00 (-87.30%)

OTC · 14 Sep 2026 19:42 UTC

Previous Close

Day Range

$0$0

Year Range

$0$0.05

Market Cap

220.51K

AVG Volume

263.11K

Trailing/Forward PE

-0/0

PEG ratio

-0

Dividend Yield

Next Earnings Date

2026-11-06

Primary Exchange

Other OTC

Revenue (USD)

SRNE Revenue (USD) by quarter
Period	Revenue (USD)
23 Q2	15.03M
23 Q1	16.25M
22 Q4	15.59M
22 Q3	17.4M
22 Q2	11.46M
22 Q1	18.39M
21 Q4	13.08M
21 Q3	12.06M
21 Q2	13.51M
21 Q1	14.26M

Net Income (USD)

SRNE Net Income (USD) by quarter
Period	Net Income (USD)
23 Q2	-95.21M
23 Q1	-139.62M
22 Q4	-223.69M
22 Q3	-90.69M
22 Q2	-219.55M
22 Q1	-40.81M
21 Q4	-144.42M
21 Q3	-119.8M
21 Q2	-166.62M
21 Q1	2.51M

Operating Income (USD)

SRNE Operating Income (USD) by quarter
Period	Operating Income (USD)
23 Q2	-77.23M
23 Q1	-106.34M
22 Q4	-169.63M
22 Q3	-110.14M
22 Q2	-91.88M
22 Q1	-106.88M
21 Q4	-104.81M
21 Q3	-90.26M
21 Q2	-100.55M
21 Q1	-84.91M

EBITDA (USD)

SRNE EBITDA (USD) by quarter
Period	EBITDA (USD)
23 Q2	-99.48M
23 Q1	-136.73M
22 Q4	-204.93M
22 Q3	-86.73M
22 Q2	-213.86M
22 Q1	-31.41M
21 Q4	-171.47M
21 Q3	-111.76M
21 Q2	-161.45M
21 Q1	7.92M

Cash Flows (USD)

SRNE Cash Flows (USD) by quarter
Period	Cash Flows (USD)
23 Q2	-55.8M
23 Q1	-49.55M
22 Q4	-72.86M
22 Q3	-65.01M
22 Q2	-83.69M
22 Q1	-85.95M
21 Q4	-74.35M
21 Q3	-84.29M
21 Q2	-82.01M
21 Q1	-50.05M

EPS (USD)

SRNE EPS (USD) by quarter
Period	EPS (USD)
23 Q2	-0.17
23 Q1	-0.26
22 Q4	-0.51
22 Q3	-0.2
22 Q2	-0.55
22 Q1	-0.12
21 Q4	-0.47
21 Q3	-0.4
21 Q2	-0.57
21 Q1	0.01

Expenses (USD)

SRNE Expenses (USD) by quarter
Period	Expenses (USD)
23 Q2	82.35M
23 Q1	98.87M
22 Q4	85.03M
22 Q3	121.98M
22 Q2	99.31M
22 Q1	110.9M
21 Q4	115.92M
21 Q3	97.06M
21 Q2	108.39M
21 Q1	89.22M

Cash & Debt (USD)

SRNE Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
23 Q2	80.64M
23 Q1	50.32M
22 Q4	49.98M
22 Q3	117.86M
22 Q2	133.6M
22 Q1	270.66M
21 Q4	126.88M
21 Q3	162.67M
21 Q2	111.7M
21 Q1	236.11M

Debt ratios

SRNE Debt ratios by quarter
Period	Debt ratios
23 Q2	-0.24
23 Q1	-0.21
22 Q4	-0.16
22 Q3	-0.13
22 Q2	-0.16
22 Q1	0.02
21 Q4	-0.25
21 Q3	-0.12
21 Q2	-0.18
21 Q1	0.38

Margins

SRNE Margins by quarter
Period	Margins
23 Q2	43.74%
23 Q1	68.09%
22 Q4	12%
22 Q3	52.48%
22 Q2	50.23%
22 Q1	68.68%
21 Q4	68.09%
21 Q3	46.58%
21 Q2	76.9%
21 Q1	76.25%

Return on Capital

SRNE Return on Capital by quarter
Period	Return on Capital
23 Q2	48.1%
23 Q1	109.57%
22 Q4	1032.31%
22 Q3	-69.65%
22 Q2	-161.71%
22 Q1	-18.04%
21 Q4	-184.84%
21 Q3	-91.22%
21 Q2	-89.8%
21 Q1	1.09%

Shares Outstanding

SRNE Shares Outstanding by quarter
Period	Shares Outstanding
23 Q2	551.28M
23 Q1	543.14M
22 Q4	435.47M
22 Q3	451.62M
22 Q2	402.8M
22 Q1	337.12M
21 Q4	308.85M
21 Q3	299.28M
21 Q2	290M
21 Q1	280.6M

Book Value Per Share (USD)

SRNE Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
23 Q2	-0.36
23 Q1	-0.23
22 Q4	-0.05
22 Q3	0.29
22 Q2	0.34
22 Q1	0.67
21 Q4	0.25
21 Q3	0.44
21 Q2	0.64
21 Q1	0.82

Total Assets (USD)

SRNE Total Assets (USD) by quarter
Period	Total Assets (USD)
23 Q2	456.69M
23 Q1	460.06M
22 Q4	472.84M
22 Q3	615.61M
22 Q2	632.13M
22 Q1	855.64M
21 Q4	694.82M
21 Q3	752.79M
21 Q2	778.92M
21 Q1	613.62M

Employee Count

SRNE Employee Count by quarter
Period	Employee Count
2022	949
2021	799
2020	502
2019	310
2018	382
2017	162
2016	154
2015	97
2014	66
2013	50

PE Ratio

SRNE PE Ratio by quarter
Period	PE Ratio
May 18	0.6
Apr 18	0.59

Free Cash Flow Yield

SRNE Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-110294.02%
Sep 26	-110294.02%
Sep 26	-73529.35%
Aug 26	-88235.22%
Aug 26	-55147.01%
Aug 26	-63025.16%
Aug 26	-88235.22%
Jul 26	-88235.22%
Jul 26	-110294.02%
Jul 26	-44117.61%
Jul 26	-63025.16%
Jul 26	-80213.84%
Jun 26	-44117.61%
Jun 26	-40106.92%
Jun 26	-49019.57%
Jun 26	-88235.22%
May 26	-88235.22%
May 26	-88235.22%
May 26	-73529.35%
May 26	-49019.57%
May 26	-88235.22%
Apr 26	-49019.57%
Apr 26	-55147.01%
Apr 26	-19181.57%
Apr 26	-13786.75%
Mar 26	-18382.34%
Mar 26	-14231.49%
Mar 26	-11609.9%
Mar 26	-9191.17%
Feb 26	-27573.51%
Feb 26	-11609.9%
Feb 26	-17647.04%
Feb 26	-17647.04%
Jan 26	-17647.04%
Jan 26	-12605.03%
Jan 26	-12605.03%
Jan 26	-14231.49%
Jan 26	-14005.59%
Dec 25	-13786.75%
Dec 25	-24509.78%
Dec 25	-11312.21%
Dec 25	-11923.68%
Nov 25	-5584.51%
Nov 25	-6787.32%
Nov 25	-4901.96%
Nov 25	-4901.96%
Oct 25	-5656.1%
Oct 25	-7352.93%
Oct 25	-6302.52%
Oct 25	-7352.93%
Oct 25	-12605.03%
Sep 25	-12605.03%
Sep 25	-8823.52%
Sep 25	-12605.03%
Sep 25	-11923.68%
Aug 25	-7352.93%
Aug 25	-10259.91%
Aug 25	-21008.39%
Aug 25	-29411.74%
Aug 25	-29411.74%
Jul 25	-31512.58%
Jul 25	-31512.58%
Jul 25	-18382.34%
Jul 25	-33936.62%
Jun 25	-20053.46%
Jun 25	-20053.46%
Jun 25	-21008.39%
Jun 25	-21008.39%
May 25	-33936.62%
May 25	-33936.62%
May 25	-40106.92%
May 25	-21008.39%
May 25	-49019.57%
Apr 25	-44117.61%
Apr 25	-49019.57%
Apr 25	-44117.61%
Apr 25	-44117.61%
Mar 25	-63025.16%
Mar 25	-63025.16%
Mar 25	-63025.16%
Mar 25	-63025.16%
Feb 25	-88235.22%
Feb 25	-73529.35%
Feb 25	-73529.35%
Feb 25	-88235.22%
Jan 25	-110294.02%
Jan 25	-88235.22%
Jan 25	-88235.22%
Jan 25	-73529.35%
Jan 25	-73529.35%
Dec 24	-63025.16%
Dec 24	-55147.01%
Dec 24	-29411.74%
Dec 24	-36764.67%
Nov 24	-29411.74%
Nov 24	-17647.04%
Nov 24	-12605.03%
Nov 24	-4411.76%
Nov 24	-16339.86%
Oct 24	-12254.89%

Price to Sales

SRNE Price to Sales by quarter
Period	Price to Sales
Sep 26	0
Sep 26	0
Sep 26	0.01
Aug 26	0
Aug 26	0.01
Aug 26	0.01
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0.01
Jul 26	0.01
Jul 26	0
Jun 26	0.01
Jun 26	0.01
Jun 26	0.01
Jun 26	0
May 26	0
May 26	0
May 26	0.01
May 26	0.01
May 26	0
Apr 26	0.01
Apr 26	0.01
Apr 26	0.02
Apr 26	0.03
Mar 26	0.02
Mar 26	0.03
Mar 26	0.03
Mar 26	0.04
Feb 26	0.01
Feb 26	0.03
Feb 26	0.02
Feb 26	0.02
Jan 26	0.02
Jan 26	0.03
Jan 26	0.03
Jan 26	0.03
Jan 26	0.03
Dec 25	0.03
Dec 25	0.02
Dec 25	0.03
Dec 25	0.03
Nov 25	0.07
Nov 25	0.06
Nov 25	0.08
Nov 25	0.08
Oct 25	0.07
Oct 25	0.05
Oct 25	0.06
Oct 25	0.05
Oct 25	0.03
Sep 25	0.03
Sep 25	0.04
Sep 25	0.03
Sep 25	0.03
Aug 25	0.05
Aug 25	0.04
Aug 25	0.02
Aug 25	0.01
Aug 25	0.01
Jul 25	0.01
Jul 25	0.01
Jul 25	0.02
Jul 25	0.01
Jun 25	0.02
Jun 25	0.02
Jun 25	0.02
Jun 25	0.02
May 25	0.01
May 25	0.01
May 25	0.01
May 25	0.02
May 25	0.01
Apr 25	0.01
Apr 25	0.01
Apr 25	0.01
Apr 25	0.01
Mar 25	0.01
Mar 25	0.01
Mar 25	0.01
Mar 25	0.01
Feb 25	0
Feb 25	0.01
Feb 25	0.01
Feb 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0.01
Jan 25	0.01
Dec 24	0.01
Dec 24	0.01
Dec 24	0.01
Dec 24	0.01
Nov 24	0.01
Nov 24	0.02
Nov 24	0.03
Nov 24	0.09
Nov 24	0.02
Oct 24	0.03

EV/EBITDA

SRNE EV/EBITDA by quarter
Period	EV/EBITDA
Nov 18	-7.2
Oct 18	-7.35
Oct 18	-7.29
Oct 18	-7.23
Oct 18	-7.12
Sep 18	-7
Sep 18	-7.03
Sep 18	-7.02
Sep 18	-6.84
Aug 18	-6.68
Aug 18	-6.66
Aug 18	-6.73
Aug 18	-6.72
Aug 18	-0.74
Jul 18	-0.73
Jul 18	-0.69
Jul 18	-0.64
Jul 18	-0.65
Jun 18	-0.64
Jun 18	-0.67
Jun 18	-0.63
Jun 18	-0.62
Jun 18	-0.61
May 18	-0.61
May 18	-0.64
May 18	-0.62
May 18	-0.39
Apr 18	-0.39
Apr 18	-0.14
Apr 18	-0.15
Apr 18	-0.15
Mar 18	-0.16
Mar 18	-0.13
Mar 18	-0.12
Mar 18	-0.12
Mar 18	-0.13
Feb 18	-0.1
Feb 18	-0.1
Feb 18	-0.13
Feb 18	-0.12
Jan 18	-0.12
Jan 18	-0.14
Jan 18	-0.16
Jan 18	-0.16
Dec 17	-0.18
Dec 17	-0.18
Dec 17	-0.19
Dec 17	-0.2
Dec 17	-0.2
Nov 17	-0.2
Nov 17	-0.2
Nov 17	-0.19
Mar 16	-19.01
Mar 16	-18.99
Feb 16	-18.98
Feb 16	-19
Feb 16	-19.03
Feb 16	-19.06
Jan 16	-19.05
Jan 16	-18.99
Jan 16	-19
Jan 16	-18.93
Dec 15	-18.83
Dec 15	-18.78
Dec 15	-18.88
Dec 15	-18.9
Dec 15	-18.88
Nov 15	-18.85
Nov 15	-18.89

Price to Book

SRNE Price to Book by quarter
Period	Price to Book
Feb 23	0.01
Feb 23	0.01
Feb 23	0.03
Feb 23	0.04
Jan 23	0.04
Jan 23	0.04
Jan 23	0.04
Jan 23	0.04
Dec 22	0.03
Dec 22	0.03
Dec 22	0.04
Dec 22	0.04
Dec 22	0.04
Nov 22	0.05
Nov 22	0.05
Nov 22	0.06
Nov 22	0.04
Oct 22	0.05
Oct 22	0.05
Oct 22	0.04
Oct 22	0.04
Sep 22	0.05
Sep 22	0.05
Sep 22	0.06
Sep 22	0.07
Sep 22	0.06
Aug 22	0.06
Aug 22	0.06
Aug 22	0.04
Aug 22	0.04
Jul 22	0.04
Jul 22	0.04
Jul 22	0.04
Jul 22	0.04
Jul 22	0.03
Jun 22	0.03
Jun 22	0.03
Jun 22	0.02
Jun 22	0.03
May 22	0.02
May 22	0.02
May 22	0.02
May 22	0.02
Apr 22	0.06
Apr 22	0.07
Apr 22	0.07
Apr 22	0.08
Apr 22	0.09
Mar 22	0.1
Mar 22	0.1
Mar 22	0.09
Mar 22	0.05
Feb 22	0.06
Feb 22	0.06
Feb 22	0.07
Feb 22	0.07
Jan 22	0.07
Jan 22	0.09
Jan 22	0.1
Jan 22	0.1
Dec 21	0.11
Dec 21	0.13
Dec 21	0.14
Dec 21	0.14
Dec 21	0.11
Nov 21	0.14
Nov 21	0.14
Nov 21	0.15
Nov 21	0.15
Oct 21	0.11
Oct 21	0.1
Oct 21	0.11
Oct 21	0.1
Oct 21	0.11
Sep 21	0.12
Sep 21	0.13
Sep 21	0.12
Sep 21	0.14
Aug 21	0.14
Aug 21	0.13
Aug 21	0.14
Aug 21	0.13
Jul 21	0.1
Jul 21	0.1
Jul 21	0.1
Jul 21	0.11
Jul 21	0.12
Jun 21	0.12
Jun 21	0.1
Jun 21	0.11
Jun 21	0.1
May 21	0.09
May 21	0.09
May 21	0.08
May 21	0.09
Apr 21	0.15
Apr 21	0.14
Apr 21	0.13
Apr 21	0.13
Apr 21	0.14

No video analysis for this stock yet. Request one from our team.

AI Analysis

Sorrento Therapeutics, Inc.

Video analysis: SRNE

Similar companies